Takeda enters new phase in clinical trial of brentuximab vedotin
Takeda Bio Development Center Ltd. said Oct. 11 it has entered a new phase in the clinical development trial in Japan of brentuximab vedotin, an antibody-drug conjugate for...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
5 results in 0.0459 seconds.
Keywords
Members
Tags
-
Japan - Takeda releases new diabetes drug in Japan
Takeda releases new diabetes drug in Japan
Takeda Pharmaceutical Co. announced on Sept. 20 that it is releasing Liovel, a fixed-dose combination tablet of Nesina and Actos, for treatment of type 2 diabetes in Japan.....
...
-
Japan - Amylin, Takeda discontinue obesity therapy treatment
Amylin, Takeda discontinue obesity therapy treatment
Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. announced Aug. 4 they are discontinuing development of pramlintide/metreleptin, which is used to treat obesity.....
...
-
France - France suspends Takeda diabetes drugs
France suspends Takeda diabetes drugs
France's drug-safety authority says it has instructed doctors not to use diabetes medications produced by Japanese pharmaceutical maker Takeda, citing an increased risk of cancer........
...
-
Takeda in Japan to manufacture H5N1 vaccine
UPDATE 1-Takeda to make flu vaccines with Baxter's help - Nikkei
Fri Jun 18, 2010 2:14pm EDTStocks
June 19 (Reuters) - Japan's largest drugmaker Takeda Pharmaceutical Co (4502.T) will resume production of influenza vaccines after...